These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22212991)

  • 1. Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome.
    Ostrowska M; Banaszkiewicz K; Kiławiec A; Róg T; Lütjohann D; Szczudlik A
    Neurol Neurochir Pol; 2011; 45(6):600-603. PubMed ID: 22212991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrotendinous xanthomatosis: a treatable ataxia.
    Clemen CS; Spottke EA; Lütjohann D; Urbach H; von Bergmann K; Klockgether T; Dodel R
    Neurology; 2005 Apr; 64(8):1476. PubMed ID: 15851751
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebrotendinous xanthomatosis].
    Burghaus L; Liu W; Haupt WF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain structural outcomes.
    Amador MDM; Masingue M; Debs R; Lamari F; Perlbarg V; Roze E; Degos B; Mochel F
    J Inherit Metab Dis; 2018 Sep; 41(5):799-807. PubMed ID: 29560583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and follow-up of children with cerebrotendinous xanthomatosis.
    van Heijst AF; Verrips A; Wevers RA; Cruysberg JR; Renier WO; Tolboom JJ
    Eur J Pediatr; 1998 Apr; 157(4):313-6. PubMed ID: 9578968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].
    Lionnet C; Carra C; Ayrignac X; Levade T; Gayraud D; Castelnovo G; Besson G; Androdias G; Vukusic S; Confavreux C; Zaenker C; De Seze J; Collongues N; Blanc F; Tranchant C; Wallon D; Hannequin D; Gerdelat-Mas A; Brassat D; Clanet M; Zephir H; Outteryck O; Vermersch P; Labauge P
    Rev Neurol (Paris); 2014; 170(6-7):445-53. PubMed ID: 24746394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
    Ko KF; Lee KW
    Singapore Med J; 2001 Jan; 42(1):30-2. PubMed ID: 11361235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment].
    Blaabjerg M; Marjanovic D
    Ugeskr Laeger; 2013 Jan; 175(5):285-6. PubMed ID: 23369332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R; Grau AJ; Schäbitz WR; Schwaninger M
    Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.
    Mukherjee AA; Chawla BP; Rathi SS; Puthran RS
    J Assoc Physicians India; 2007 Sep; 55():655-7. PubMed ID: 18051740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.
    Suh S; Kim HK; Park HD; Ki CS; Kim MY; Jin SM; Kim SW; Hur KY; Kim KW; Kim JH
    Eur J Med Genet; 2012 Jan; 55(1):71-4. PubMed ID: 21958693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebrotendinous xanthomatosis, a rare, severe, but treatable metabolic disorder].
    Delstanche S; Deflandre T; Otto B; Tshibanda L; Simoni P; Moonen G
    Rev Med Liege; 2013 Apr; 68(4):171-6. PubMed ID: 23755706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
    Takahashi M; Okazaki H; Tada H; Ishibashi S
    J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis.
    Stelten BML; Bonnot O; Huidekoper HH; van Spronsen FJ; van Hasselt PM; Kluijtmans LAJ; Wevers RA; Verrips A
    J Inherit Metab Dis; 2018 Jul; 41(4):641-646. PubMed ID: 28894950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebrotendinous xanthomatosis. Report of one case].
    Contreras JP; Guajardo G; Martínez A; López I; Cea G
    Rev Med Chil; 2019 May; 147(5):658-662. PubMed ID: 31859899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene.
    Yoshinaga T; Sekijima Y; Koyama S; Maruyama K; Yoshida T; Kato T; Ikeda S
    Intern Med; 2014; 53(23):2725-9. PubMed ID: 25447658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts.
    Tibrewal S; Duell PB; DeBarber AE; Loh AR
    J AAPOS; 2017 Dec; 21(6):505-507. PubMed ID: 29079218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies.
    Verrips A; Dotti MT; Mignarri A; Stelten BML; Verma S; Federico A
    Neurol Sci; 2020 Apr; 41(4):943-949. PubMed ID: 31863326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrotendinous xanthomatosis: a treatable disease with juvenile cataracts as a presenting sign.
    Monson DM; DeBarber AE; Bock CJ; Anadiotis G; Merkens LS; Steiner RD; Stout AU
    Arch Ophthalmol; 2011 Aug; 129(8):1087-8. PubMed ID: 21825196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.